NCT07046728View on ClinicalTrials.gov

Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL

Not yet recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

March 1, 2026

Conditions
Injections Intralesional
Interventions
OTHER

Efficay and Safety of DAROMUN on patient treated by intralesionnal injection: DAROMEL

Observationnal study with clincal data collection to evaluate the efficiency and the tolerability of DAROMUN

Trial Locations (1)

06000

Chu de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT07046728 - Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL | Biotech Hunter | Biotech Hunter